Cargando…
Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway
Colon cancer is one of the most common digestive tract malignancies, having the second highest mortality rate among all tumors, with a five-year survival of advanced patients of only 10%. Efficient, targeted drugs are still lacking in treating colon cancer, so it is urgent to explore novel druggable...
Autores principales: | Wang, Xi, Shao, Gang, Hong, Xiangyu, Shi, Yue, Zheng, Yiting, Yu, Yucheng, Fu, Caiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862434/ https://www.ncbi.nlm.nih.gov/pubmed/36678567 http://dx.doi.org/10.3390/ph16010070 |
Ejemplares similares
-
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
por: Yan, Zhibin, et al.
Publicado: (2022) -
Advancements of Annexin A1 in inflammation and tumorigenesis
por: Shao, Gang, et al.
Publicado: (2019) -
Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells
por: Wynn, Michelle L, et al.
Publicado: (2014) -
Annexins in Adipose Tissue: Novel Players in Obesity
por: Grewal, Thomas, et al.
Publicado: (2019) -
Annexins: players of single cell wound healing and regeneration
por: Häger, Swantje Christin, et al.
Publicado: (2019)